Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GNA13P1 (GNA13 pseudogene 1) is a pseudogene and does not produce a functional protein. Pseudogenes arise from duplication or retrotransposition of ancestral genes but accumulate disabling mutations that prevent them from being functional. GNA13P1 resembles the G protein subunit alpha 13 (GNA13) at the DNA level but lacks evidence of protein-coding potential or biological activity. There is no published evidence indicating a role in disease, drug targeting, or any regulatory function. It is not considered a molecular target in therapeutics or diagnostics[7]. This is distinct from GNA13 (G protein subunit alpha 13), a recognized signaling protein and cancer-related target[1][2][3]. GNA13P1 is a pseudogene, not a validated molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GNA13 pseudogene 1 (GNA13P1).